Skip to main content

Human trials take inflating needle-filled smart pills closer to market

Rani updated video 2018

Who wouldn’t want to be able to replace regular painful injections with a smart pill? That’s what San Jose, California-based company Rani Therapeutics has developed with its innovative RaniPill. While the RaniPill looks like a regular capsule, when its outer layer dissolves in the intestine, a miniature balloon inflates inside and pushes a tiny needle into the intestinal muscular wall to inject its contents. Because the intestine has no pain receptors, all of this happens without the patient feeling a thing. The balloon then deflates, and the pill can be passed via the, err, normal channels.

Recommended Videos

On the surface, this high-tech pill of the future sounds like the kind of Rube Goldberg solution that will never make it past initial prototypes. You’d be wrong, however, since the RaniPill just underwent a human trial, taking it one step closer to market. In the trial, participants were given RaniPills containing octreotide, a drug prescribed as part of the treatment for certain types of tumors found in the intestines and pancreas.

RaniPill in hand
Rani Therapeutics

“The phase one clinical study of Octreotide-RP was conducted in Australia with 58 healthy adult volunteers,” Mir Imran, CEO and founder of Rani Therapeutics, told Digital Trends. “The test group was comprised of both male and female subjects aged 18 to 55. Of the 58 participants, 52 were dosed with Octreotide-RP, the RaniPill loaded with octreotide. A control group of six participants was given an intravenous injection of an identical dose of octreotide.”

The study confirmed the RaniPill was well tolerated, meaning the subjects could easily swallow it and did not feel any pain or other unpleasant sensations. It also demonstrated that the RaniPill can safely and effectively deliver drugs into the intestinal wall in the appropriate dosage.

The company is planning further tests later in the year, and is in discussions with pharmaceutical companies and regulators in the United States and Europe. Initially, the company hopes to use the RaniPill to deliver nine drugs, including octreotide and insulin.

“[When it will make it to market depends] on the timing of FDA approval,” Imran continued. “We are engaged in discussions with the FDA, and expect approval in two to three years.”

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
ChatGPT’s awesome Deep Research gets a light version and goes free for all
Deep Research option for ChatGPT.

There’s a lot of AI hype floating around, and it seems every brand wants to cram it into their products. But there are a few remarkably useful tools, as well, though they are pretty expensive. ChatGPT’s Deep Research is one such feature, and it seems OpenAI is finally feeling a bit generous about it. 

The company has created a lightweight version of Deep Research that is powered by its new o4-mini language model. OpenAI says this variant is “more cost-efficient while preserving high quality.” More importantly, it is available to use for free without any subscription caveat. 

Read more
Star Wars legend Ian McDiarmid gets questions about the Emperor’s sex life
Ian McDiarmid as the Emperor in Star Wars: The Rise of Skywalker.

This weekend, the Star Wars: Revenge of the Sith 20th anniversary re-release had a much stronger performance than expected with $25 million and a second-place finish behind Sinners. Revenge of the Sith was the culmination of plans by Chancellor Palpatine (Ian McDiarmid) that led to the fall of the Jedi and his own ascension to emperor. Because McDiarmid's Emperor died in his first appearance -- 1983's Return of the Jedi -- Revenge of the Sith was supposed to be his live-action swan song. However, Palpatine's return in Star Wars: Episode IX -- The Rise of Skywalker left McDiarmid being asked questions about his character's comeback, particularly about his sex life and how he could have a granddaughter.

While speaking with Variety, McDiarmid noted that fans have asked him "slightly embarrassing questions" about Palpatine including "'Does this evil monster ever have sex?'"

Read more
Waymo and Toyota explore personally owned self-driving cars
Front three quarter view of the 2023 Toyota bZ4X.

Waymo and Toyota have announced they’re exploring a strategic collaboration—and one of the most exciting possibilities on the table is bringing fully-automated driving technology to personally owned vehicles.
Alphabet-owned Waymo has made its name with its robotaxi service, the only one currently operating in the U.S. Its vehicles, including Jaguars and Hyundai Ioniq 5s, have logged tens of millions of autonomous miles on the streets of San Francisco, Los Angeles, Phoenix, and Austin.
But shifting to personally owned self-driving cars is a much more complex challenge.
While safety regulations are expected to loosen under the Trump administration, the National Highway Traffic Safety Administration (NHTSA) has so far taken a cautious approach to the deployment of fully autonomous vehicles. General Motors-backed Cruise robotaxi was forced to suspend operations in 2023 following a fatal collision.
While the partnership with Toyota is still in the early stages, Waymo says it will initially study how to merge its autonomous systems with the Japanese automaker’s consumer vehicle platforms.
In a recent call with analysts, Alphabet CEO Sundar Pichai signaled that Waymo is seriously considering expanding beyond ride-hailing fleets and into personal ownership. While nothing is confirmed, the partnership with Toyota adds credibility—and manufacturing muscle—to that vision.
Toyota brings decades of safety innovation to the table, including its widely adopted Toyota Safety Sense technology. Through its software division, Woven by Toyota, the company is also pushing into next-generation vehicle platforms. With Waymo, Toyota is now also looking at how automation can evolve beyond assisted driving and into full autonomy for individual drivers.
This move also turns up the heat on Tesla, which has long promised fully self-driving vehicles for consumers. While Tesla continues to refine its Full Self-Driving (FSD) software, it remains supervised and hasn’t yet delivered on full autonomy. CEO Elon Musk is promising to launch some of its first robotaxis in Austin in June.
When it comes to self-driving cars, Waymo and Tesla are taking very different roads. Tesla aims to deliver affordability and scale with its camera, AI-based software. Waymo, by contrast, uses a more expensive technology relying on pre-mapped roads, sensors, cameras, radar and lidar (a laser-light radar), that regulators have been quicker to trust.

Read more